These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1980734)
21. Importance of the hepatic arterial glucose level in generation of the portal signal in conscious dogs. Hsieh PS; Moore MC; Neal DW; Cherrington AD Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E284-92. PubMed ID: 10913027 [TBL] [Abstract][Full Text] [Related]
22. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels. Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104 [TBL] [Abstract][Full Text] [Related]
24. Accuracy of C-peptide:insulin molar ratio as a measure of hepatic removal of insulin. Berzins R; Wieczorek KR; Rajotte RV; Molnar GD; Tam YK; McGregor JR; Fawcett DM Diabetes Res Clin Pract; 1987 Nov; 4(1):37-43. PubMed ID: 2891470 [TBL] [Abstract][Full Text] [Related]
25. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region. Dardevet D; Moore MC; Neal D; DiCostanzo CA; Snead W; Cherrington AD Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E75-81. PubMed ID: 15026303 [TBL] [Abstract][Full Text] [Related]
26. [Role of the liver in the regulation of blood levels of insulin, C-peptide and glucose]. Kniazev IuA; Vakhrusheva LL; Stupin IV Probl Endokrinol (Mosk); 1981; 27(4):39-41. PubMed ID: 7027247 [TBL] [Abstract][Full Text] [Related]
27. Magnitude of negative arterial-portal glucose gradient alters net hepatic glucose balance in conscious dogs. Pagliassotti MJ; Myers SR; Moore MC; Neal DW; Cherrington AD Diabetes; 1991 Dec; 40(12):1659-68. PubMed ID: 1684554 [TBL] [Abstract][Full Text] [Related]
29. Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery. Moore MC; Burish MJ; Farmer B; Neal DW; Pan C; Cherrington AD Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E845-53. PubMed ID: 12773306 [TBL] [Abstract][Full Text] [Related]
30. Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide. Pelkonen R; Kallio H; Suoranta H; Karonen SL Acta Endocrinol (Copenh); 1981 Aug; 97(4):496-502. PubMed ID: 7023164 [TBL] [Abstract][Full Text] [Related]
31. Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin. Camacho RC; Pencek RR; Lacy DB; James FD; Wasserman DH Diabetes; 2004 Feb; 53(2):285-93. PubMed ID: 14747277 [TBL] [Abstract][Full Text] [Related]
32. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767 [TBL] [Abstract][Full Text] [Related]
33. Effect of a selective rise in hepatic artery insulin on hepatic glucose production in the conscious dog. Sindelar DK; Igawa K; Chu CA; Balcom JH; Neal DW; Cherrington AD Am J Physiol; 1999 Apr; 276(4):E806-13. PubMed ID: 10198319 [TBL] [Abstract][Full Text] [Related]
34. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver. Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932 [TBL] [Abstract][Full Text] [Related]
35. Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog. Kaden M; Harding P; Field JB J Clin Invest; 1973 Aug; 52(8):2016-28. PubMed ID: 4719675 [TBL] [Abstract][Full Text] [Related]
36. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man. Saccà L; Cicala M; Trimarco B; Ungaro B; Vigorito C J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524 [TBL] [Abstract][Full Text] [Related]
37. Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans. Bratusch-Marrain PR; Waldhäusl WK; Gasić S; Hofer A Metabolism; 1984 Feb; 33(2):151-7. PubMed ID: 6141519 [TBL] [Abstract][Full Text] [Related]
38. Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations. Boden G; Essa N; Owen OE; Reichle FA J Clin Invest; 1974 Apr; 53(4):1185-93. PubMed ID: 4815082 [TBL] [Abstract][Full Text] [Related]
39. Somatostatin impairs clearance of exogenous insulin in humans. Ipp E; Sinai Y; Bar-Oz B; Nesher R; Cerasi E Diabetes; 1987 May; 36(5):673-7. PubMed ID: 2883058 [TBL] [Abstract][Full Text] [Related]
40. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes. Shilo S; Sotsky M; Shamoon H J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]